SMAD6 and breast cancer: (137) identified SMAD6 as a hub gene contributing to the differences between two novel subtypes of BC with completely different biological characteristics, including immune microenvironment and drug sensitivity with ML classifiers, and further investigated the role of SMAD6 in BC in the single-cell transcriptome data.